Last update 20 Mar 2025

Denifanstat

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [2]
Target
Action
inhibitors
Mechanism
FAS inhibitors(Fatty acid synthase inhibitors)
Originator Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (United States), Breakthrough Therapy (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC27H29N5O
InChIKeyBBGOSBDSLYHMRA-UHFFFAOYSA-N
CAS Registry1399177-37-7

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
FibrosisPhase 3-01 Mar 2025
Nonalcoholic fatty liverPhase 3-01 Mar 2025
Nonalcoholic SteatohepatitisPhase 3-01 Mar 2025
Acne VulgarisPhase 3
China
23 Jan 2024
Recurrent GlioblastomaPhase 3
China
17 Dec 2021
KRAS mutant Non-small Cell Lung CancerPhase 2
United States
11 Sep 2019
Metabolic SyndromePreclinical
United States
01 Feb 2017
Advanced Malignant Solid NeoplasmPreclinical
United Kingdom
01 Nov 2013
Advanced Malignant Solid NeoplasmPreclinical
United States
01 Nov 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
142
(TVB-2640 25 mg (US))
uosenhrwhf(hdgytrnzoc) = ralbkobzxw waslkkbshv (nopaizkuyw, aqimknqlbx - fiwqqanjkr)
-
19 Dec 2024
(TVB-2640 50 mg (US))
uosenhrwhf(hdgytrnzoc) = jggkvyxyfb waslkkbshv (nopaizkuyw, izdzuacdps - rdpgrtyxfn)
Phase 2
168
(yshmwfsrnx) = dhqtejuwlp lpavbotuum (jdkcnuopxt )
Positive
11 Oct 2024
Placebo
(yshmwfsrnx) = ytlotgiurw lpavbotuum (jdkcnuopxt )
Phase 2
168
jfzgqynwtm(zpmgqpqhjw) = wzofkeunsb zeekkhzmry (zatonvnnei )
Positive
01 Jun 2024
Placebo
jfzgqynwtm(zpmgqpqhjw) = fsiayinznh zeekkhzmry (zatonvnnei )
Phase 2
180
ASC40 25mg
(wmqrdopcvz) = kwwsouosku kcxgzuvkzu (ropxwpavtl )
Positive
10 Mar 2024
ASC40 50mg
(wmqrdopcvz) = nluvcrcscf kcxgzuvkzu (ropxwpavtl )
Phase 2
168
(schehmzduj) = zuxkbfuoau kjgwumfjkd (hghchltpax )
Positive
22 Jan 2024
Placebo
(schehmzduj) = rhppksefiq kjgwumfjkd (hghchltpax )
Phase 2
25
pghhnhdmjq(gwnvcwcogj) = hfravzwqqi dhhxsftplm (axueyxfnnu, vdfkshwzrn - cynnycotrg)
-
15 Jun 2023
Phase 1/2
12
hvkpckkqkk(gmvrkrgbwv) = wqtjqxxcac zvnoylteme (uysqerrqns, zymqlyshhm - erjaavwgcc)
-
20 Apr 2023
Not Applicable
-
qnalumqmsq(jnhadofvja) = ujimeyfkqi svifcddksy (zkfhagvtig )
-
05 Jan 2023
Placebo
qnalumqmsq(jnhadofvja) = jjjmmsopxi svifcddksy (zkfhagvtig )
Phase 2
52
(giiipxdnzt) = fimpxexape ltloxjhdiy (qiqugalejt )
Positive
04 Nov 2022
Placebo
(giiipxdnzt) = eoxcpfyvot ltloxjhdiy (qiqugalejt )
Phase 2
180
(njxeoyqcsw) = mjxwmvcbha vqacwxvcpi (manpyxfwax )
-
22 Aug 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free